المؤلفون: Georgievska, Biljana, Kirik, Deniz, Björklund, Anders

المصدر: Experimental Neurology. 177(2):461-474

مصطلحات موضوعية: Neural Pathways: drug effects, Lentivirus: genetics, Luminescent Proteins: biosynthesis, Luminescent Proteins: genetics, Motor Activity: drug effects, Nerve Growth Factors: biosynthesis, Nerve Growth Factors: genetics, Nerve Growth Factors: pharmacology, Time, Tyrosine 3-Monooxygenase: deficiency, Tyrosine 3-Monooxygenase: metabolism, Horizontal, Substantia Nigra: pathology, Recovery of Function: genetics, Substantia Nigra: enzymology, Recovery of Function: drug effects, Sprague-Dawley, Neural Pathways: enzymology, Neural Pathways: pathology, Oxidopamine, Parkinsonian Disorders: chemically induced, Parkinsonian Disorders: physiopathology, Rats, Animal, Down-Regulation, Female, Gene Transfer, Animal: drug effects, Cell Count, Corpus Striatum: enzymology, Corpus Striatum: pathology, Disease Models, enzymology, Axons: pathology, Behavior, drug effects, Axons, Medicin och hälsovetenskap, Klinisk medicin, Neurologi, Medical and Health Sciences, Clinical Medicine, Neurology

URL الوصول: https://lup.lub.lu.se/record/111209
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12429192&dopt=Abstract
http://dx.doi.org/10.1006/exnr.2002.8006

المصدر: Brain, 133 (Pt 6

مصطلحات الفهرس: Sciences bio-médicales et agricoles, Age of Onset, Amino Acid Metabolism, Inborn Errors -- drug therapy -- genetics -- metabolism, Brain -- metabolism, Brain Diseases -- drug therapy -- genetics -- metabolism, Catecholamines -- biosynthesis, Child, Preschool, Disease Progression, Dopamine Agents -- therapeutic use, Homovanillic Acid -- cerebrospinal fluid, Humans, Hydroxyindoleacetic Acid -- cerebrospinal fluid, Hypokinesia -- drug therapy -- genetics -- metabolism, Infant, Levodopa -- therapeutic use, Muscle Rigidity -- drug therapy -- genetics -- metabolism, Mutation, Missense, Phenotype, Promoter Regions, Genetic, Severity of Illness Index, Tyrosine 3-Monooxygenase -- deficiency -- genetics, Cerebrospinal fluid, Dystonia, L-dopa, Neurotransmitters, Tyrosine hydroxylase, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article

URL: https://dipot.ulb.ac.be/dspace/bitstream/2013/111307/3/doi_91554.pdf
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/111307
http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL

المصدر: Brain, 133 (Pt 6

مصطلحات الفهرس: Sciences bio-médicales et agricoles, Age of Onset, Amino Acid Metabolism, Inborn Errors -- drug therapy -- genetics -- metabolism, Brain -- metabolism, Brain Diseases -- drug therapy -- genetics -- metabolism, Catecholamines -- biosynthesis, Child, Preschool, Disease Progression, Dopamine Agents -- therapeutic use, Homovanillic Acid -- cerebrospinal fluid, Humans, Hydroxyindoleacetic Acid -- cerebrospinal fluid, Hypokinesia -- drug therapy -- genetics -- metabolism, Infant, Levodopa -- therapeutic use, Muscle Rigidity -- drug therapy -- genetics -- metabolism, Mutation, Missense, Phenotype, Promoter Regions, Genetic, Severity of Illness Index, Tyrosine 3-Monooxygenase -- deficiency -- genetics, Cerebrospinal fluid, Dystonia, L-dopa, Neurotransmitters, Tyrosine hydroxylase, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article

URL: https://dipot.ulb.ac.be/dspace/bitstream/2013/111307/3/doi_91554.pdf
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/111307
http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL